Skip to content

Efficacy and safety of ciprofol for the sedation/anesthesia in patients undergoing artificial abortion

Efficacy and safety of ciprofol for the sedation/anesthesia in patients undergoing artificial abortion

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066110
Enrollment
Unknown
Registered
2022-11-24
Start date
2022-12-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pianless abortion

Interventions

ciprofol group:Anesthesia with ciprofol and sufentanil
propofol group:Anesthesia with propofol and sufentanil

Sponsors

Shenzhen Longhua District People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old; 2. ASA grade I or II; 3. BMI 18 - 28 kg/m^2; 4. Whether there is any indication of painful abortion and the gestational age is <= 10 weeks; 5. No contraindication of useless drugs; 6. No basic diseases such as hypertension, heart disease, bronchial asthma, etc.; 7. No gynecological diseases; 8. The patient signed an informed consent form and agreed to actively cooperate with the whole process of the test, with good compliance.

Exclusion criteria

Exclusion criteria: 1. Past cognitive dysfunction; 2. Persons with history of alcohol or drug abuse 3. Subjects who have participated in any clinical trial as subjects within 3 months before enrollment; 4. Subjects whose basic heart rate is less than 50 times/min, systolic blood pressure is less than 90 mmHg, diastolic blood pressure is less than 60 mmHg, and blood oxygen saturation is less than 94%.

Design outcomes

Primary

MeasureTime frame
blood pressure;heart rate;Respiratory rate;Spo2;

Secondary

MeasureTime frame
BIS value;Pain degree of injection pain;The degree of pain, sedation, vomiting and chills 30 minutes after awakening;Satisfaction of painless abortion;Telephone follow-up of subjects;

Countries

China

Contacts

Public ContactKuang Xin

Shenzhen Longhua District People's Hospital

kx6924@126.com+86 13684996516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026